Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis

British Journal of Cancer

Volumn 75, Issue 3, 1997, Pages 396-402

  Cheng, P ^a   Schmutte, C ^a   Cofer, K F ^a   Felix, J C ^a   Yu, M C ^a   Dubeau, L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

DNA methylation; Ovarian cancer; Tumour progression

Indexed keywords

DNA; MYOD PROTEIN;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CYSTADENOMA; DNA METHYLATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031016235     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.64     Document Type: Article

References (45)

1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM and Belmont JW (1992) Methylation of Hpa11 and Hha1 sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51: 1229-1234
2. Antequera F, Boyes J and Bird A (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503-514
3. Balmain A (1995) Exploring the bowels of DNA methylation. Curr Biol 5: 1013-1016
4. Bhave MR, Wilson MJ and Poirier LA (1988) c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 9: 343-348
5. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209-213
6. Bird AP (1992) The essentials of DNA methylation. Cell 70: 5-8
7. Braun T, Bober E, Rudnicki MA, Jaenisch R and Arnold HH (1994) MyoD expression marks the onset of skeletal myogenesis in myf-5 mutant mice. Development 120: 3083-3092
8. Cheng PC, Gosewehr J, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela B, Godorov G and Dubeau L (1996) Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst 88: 510-518
9. Dixon WJ and Massey FJ (1969) Introduction to Statistical Analysis. 3rd ed. McGraw-Hill Book Company: New York
10. Ehlen T and Dubeau L (1990) Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncongene 5: 219-223
11. Ehrlich M and Wang RY (1981) 5-Methylcytosine in eukaryotic DNA. Science 212: 1350-1357
12. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
13. Feinberg AP and Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92
14. Feinberg AP, Gehrke CW, Kuo KC and Ehrlich M (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48: 1159-1161
15. Felgner J, Kreipe H, Heidorn K, Jaquet K, Zschunke F, Radzun HJ and Parwaresch MR (1991) Increased methylation of the c-fms proto-oncogene in acute myelomonocytic leukemias. Pathobiology 59: 293-298
16. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW and Ehrlich M (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11: 6883-6894
17. Gehrke CW, Mccune RA, Gama-Sosa M, Ehrlich M and Kuo KC (1984) Quantitative reversed-phase high-performance liquid chromatography of major and modified nucleosides in DNA. J Chromatography 301: 199-219
18. Goelz SE, Vogelstein B, Hamilton SR and Feinberg AP (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187-190
19. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen TT, Beart RW, van Tornout JM and Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535
20. Greger V, Passarge E, Hopping W, Messmer E and Horsthemke B (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83: 155-158
21. Hanada M, Delia D, Aello A, Stadtmauer E and Reed JC (1993) Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82: 1820-1828
22. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR and Linehan WM and Baylin SB (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704
23. Jones PA, Wolkowicz MJ, Rideout WM, Gonzalez FA, Marziasz CM, Coetzee GA and Tapscott SJ (1990) De novo methylation of the MyoD CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87: 6117-6121
24. Keshet I, Yisraeli J and Cedar H (1985) Effect of regional DNA methylation on gene expression. Proc Natl Acad Sci USA 82: 2560-2564
25. Kurman RJ and Trimble CL (1993) The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 12: 120-127
26. Laird PW and Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3: 1487-1495
27. Li E, Bestor T-H and Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926
28. Li E, Beard C and Jaenisch R (1993) Role for DNA methylation in genomic imprinting. Nature 366: 362-365
29. Lipsanen V, Leinonen P, Alhonen L and Janne J (1988) Hypomethylation of ornithine decarboxylase gene and erb-A1 oncogene in human chronic lymphatic leukemia. Blood 72: 2042-2044
30. Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J, Isaacs W, Linehan M and Baylin SB (1993) Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res 53: 2719-2722
31. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger P, Baylin SB and Sidransky D (1995) CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1: 686-692
32. Mohandas T, Sparkes RS and Shapiro LJ (1981) Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211: 393-396
33. Munzel PA, Pfohl LA, Rohrdanz E, Keith G, Dirheimer G and Bock KW (1991) Site-specific hypomethylation of c-myc proto-oncogene in liver nodules and inhibition of DNA methylation by N-nitrosomorpholine. Biochem Pharmacol 42: 365-371
34. Nelkin BD, Przepiorka D, Burke PJ, Thomas ED and Baylin SB (1991) Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. Blood 77: 2431-24 34
35. Ray JS, Harbison ML, McClain RM and Goodman JI (1994) Alterations in the methylation status and expression of the rat oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse live tumors. Mol Carcinogen 9: 155-166
36. Rideout WM, Eversole-Cire P, Spruck CH, Hustad CM, Coetzec GA, Gonzales F and Jones PA (1994) Progressive increases in the methylation status and heterochromafinization of the myoD CpG island during oncogenic transformation. Mol Cell Biol 14: 6143-6152
37. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM and Dryja TP (1991) Allele-specitic hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48: 880-888
38. Selig S, Ariel M, Goitein R, Marcus M and Cedar H (1988) Regulation of mouse satellite DNA replication time. EMBO J 7: 419-426
39. Sharrard RM, Royds JA, Rogers S and Shorthouse AJ (1992) Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer 65: 667-672
40. Sleddens HF, Oostra BA, Brinkmann AO and Trapman J (1992) Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res 20: 1427
41. Spruck CH, Rideout WM and Jones PA (1993) DNA methylation and cancer. In DNA Methylation: Molecular Biology and Biological Significance. Jost JP and Saluz HP, (eds) pp. 487-509 Birkhauser: Basle
42. Vertino PM, Spillare EA, Harris CC and Baylin SB (1993) Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. Cancer Res 53: 1684-1689
43. Vogelstein B, Fearon ER, Hamilton SR and Feinberg AP (1985) Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 227: 642-645
44. Zheng J, Wan M, Zweizig S, Velicescu M, Yu MC and Dubeau L (1993) Histologically benign and low grade malignant tumors adjacent to high grade ovarian carcinomas are not pre-existing precursor lesions. Cancer Res 53: 4138-4142
45. Zheng JP, Benedict WF, Xu H-J, Hu S-X, Kim TM, Velicescu M, Wan MH, Cofer KF and Dubeau L (1995) Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas acid solitary cystadenomas. J Natl Cancer Inst 87: 1146-1153